Showing results (51-60 of 636) with videos related to
Sort By:
Pageof 64
Clinical Endocrinology|October 1, 1989
A close correlation between the inhibitory effects of insulin-like growth factor-I and SMS 201-995 on growth hormone release by acromegalic pituitary tumours in vitro and in vivoS W Lamberts, P van Koetsveld, L HoflandHormone Research|January 1, 1988
Somatostatin receptors in normal and tumoral tissueJ C Reubi, S W Lamberts, R MaurerClinical Pharmacology and Therapeutics|November 1, 1984
Mechanism of action and tolerance of mesulergineS W Lamberts, J G Klÿn, R OosteromThe Prostate. Supplement|November 1, 2000
The male climacterium: clinical signs and symptoms of a changing endocrine environmentA W van den Beld, S W LambertsActa Endocrinologica|June 1, 1989
The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's diseaseS W Lamberts, P Uitterlinden, J M KlijnThe Journal of Clinical Endocrinology and Metabolism|October 1, 1987
SMS 201-995 induces a continuous decline in circulating growth hormone and somatomedin-C levels during therapy of acromegalic patients for over two yearsS W Lamberts, P Uitterlinden, E del PozoActa Neurochirurgica|January 1, 1986
Sex steroid receptors in human meningiomasG Blaauw, M A Blankenstein, S W LambertsActa Endocrinologica|May 1, 1985
Studies on the glucocorticoid-receptor blocking action of RU 38486 in cultured ACTH-secreting human pituitary tumour cells and normal rat pituitary cellsS W Lamberts, E G Bons, P UitterlindenActa Neuropathologica|January 1, 1983
Relationship between cytological picture and hormone secretion by human pituitary adenomas in cell cultureS Z Stefanko, S W Lamberts, R OosteromNeuroscience Letters|October 8, 1986
Somatostatin binding sites in human leptomeninxJ C Reubi, R Maurer, S W LambertsPageof 64